Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Return on Sales (2016)

Historic Return on Sales for Tenax Therapeutics (TENX) over the last 7 years, with Q1 2016 value amounting to 5161.37%.

  • Tenax Therapeutics' Return on Sales changed N/A to 5161.37% in Q1 2016 from the same period last year, while for Mar 2016 it was 5161.37%, marking a year-over-year change of. This contributed to the annual value of 765.35% for FY2024, which is 4414300.0% up from last year.
  • As of Q1 2016, Tenax Therapeutics' Return on Sales stood at 5161.37%.
  • In the past 5 years, Tenax Therapeutics' Return on Sales registered a high of 5161.37% during Q4 2015, and its lowest value of 70.83% during Q2 2013.
  • Over the past 5 years, Tenax Therapeutics' median Return on Sales value was 13.24% (recorded in 2012), while the average stood at 929.02%.
  • Its Return on Sales has fluctuated over the past 5 years, first skyrocketed by 1642100bps in 2012, then crashed by -2993100bps in 2013.
  • Tenax Therapeutics' Return on Sales (Quarter) stood at 3.01% in 2012, then plummeted by -2018bps to 63.77% in 2013, then fell by -11bps to 70.83% in 2014, then soared by 7387bps to 5161.37% in 2015, then changed by 0bps to 5161.37% in 2016.
  • Its Return on Sales was 5161.37% in Q1 2016, compared to 5161.37% in Q4 2015 and 70.83% in Q1 2014.